New ADHD test a 'breakthrough,' say medical experts - KTUL.com - Tulsa, Oklahoma - News, Weather & Sports

New ADHD test a 'breakthrough,' say medical experts

Posted: Updated:

MOUNT PLEASANT, S.C. (WCIV) -- There is a new weapon in the fight against ADHD.

A new testing device called NEBA is helping to diagnosis ADHD in kids in a whole new way. Medical professionals are calling it a brainwave breakthrough device to diagnosis the neurological disorder.

NEBA is an FDA-approved brainwave test for children 6 to 17 years of age that looks at brainwaves as the biomarker for ADHD.

Dr. Camille Washington of ADHD Charleston is the first physician in the state of South Carolina to use the NEBA system.

"These days it is very important to make sure there is not an over diagnosed so it gives us a very valuable piece of objective information on whether they could have ADHD," Washington said."The test is very safe and effective, it takes about 10 minutes, so the worst aspect is kids tell me it is a little boring."

And Dr. Washington said it's a good things kids are bored because it makes it even more accurate in measuring ADHD. Symptoms of the disorder include hyperactivity, impulsivity, distractibility, and problems sitting still.

Dr. Washington said risks for not properly being diagnosed with ADHD can include depression, anxiety, difficulties at school, and self esteem issues.

"It takes only 10 minutes; it is non-invasive, a very easy test to do in the office. It is pretty kid-friendly because there are no needles or anything that hurts, and anything that gives us an objective piece of information to help us diagnosis ADHD and prevent misdiagnosis is very important," she said.

Medical studies show around 5 to 15 percent of kids in any given community have ADHD.


  • Stefanie Bainum

    Email: sbainum@abcnews4.com Reporter Profile




Most Popular

Stories
Videos

Like Us On Facebook


Powered by WorldNow

P.O. Box 8 Tulsa, OK 74101-0008

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and KTUL. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.